Zobrazeno 1 - 10
of 62
pro vyhledávání: '"David G. Witte"'
Autor:
Uwe Müller, Teresa Ellis, Wayne R. Buck, Bradley A. Hooker, Ann Tovcimak, Nathan R. Rustay, Steven C. Cassar, Dancia Scharf, Jeffrey F. Waring, Kevin K.W. Wang, Jinhe Li, Andreas Jeromin, David G. Witte
Publikováno v:
Journal of Neuroscience Methods. 192:249-253
Cerebrospinal fluid (CSF) is commonly used for assessing biomarkers of drug efficacy or disease progression in the central nervous system. Studies of CSF from pre-clinical species can characterize biomarkers for use in clinical trials. However, obtai
Autor:
Arthur A. Hancock, Jill M. Wetter, Kennan C. Marsh, Prisca Honore, Gin C. Hsieh, Anita K. Salyers, Prasant Chandran, Timothy A. Esbenshade, Marlon D. Cowart, Joe Mikusa, Jorge D. Brioni, Erica J. Wensink, Madhavi Pai, Thomas R. Miller, Scott J. Baker, Chang Z. Zhu, David G. Witte
Publikováno v:
Pharmacology Biochemistry and Behavior. 95:41-50
The histamine H(4) receptor (H(4)R) is expressed primarily on cells involved in inflammation and immune responses. To determine the potential role of H(4)R in pain transmission, the effects of JNJ7777120, a potent and selective H(4) antagonist, were
Autor:
J. L. Baranowski, David G. Witte, RM Adair, K. C. Marsh, Jorge D. Brioni, AM Manelli, Tracy L. Carr, Cowart, H. Liu, Jill M. Wetter, Carolyn A. Cuff, Betty B. Yao, Timothy A. Esbenshade, M. I. Strakhova, TA Vortherms, L Rundell, Auriléia Aparecida de Brito, Thomas R. Miller, Mcpherson Michael J, BM Bettencourt
Publikováno v:
British Journal of Pharmacology. 157:44-54
Background and purpose: The histamine H4 receptor is widely expressed in cells of immune origin and has been shown to play a role in a variety of inflammatory processes mediated by histamine. In this report, we describe the in vitro and in vivo anti-
Autor:
Peter van Meer, Marlon D. Cowart, Marina Strakhova, David G. Witte, John L. Baranowski, Rob Leurs, Arthur A. Hancock, Brian R. Estvander, Gerold Bongers, Thomas R. Miller, Kathleen M. Krueger, Remko A. Bakker, Timothy A. Esbenshade
Publikováno v:
The Journal of Pharmacology and Experimental Therapeutics, 323(3), 888-98. American Society for Pharmacology and Experimental Therapeutics
Bongers, G M, Krueger, K M, Miller, T R, Baranowski, J L, Estvander, B R, Witte, D G, Strakhova, M I, van der Meer, P, Bakker, R A, Cowart, M D, Hancock, A A, Esbenshade, T A & Leurs, R 2007, ' An 80-amino acid deletion in the third intracellular loop of a naturally occurring human histamine H3 isoform confers pharmacological differences and constitutive activity ', The Journal of Pharmacology and Experimental Therapeutics, vol. 323, no. 3, pp. 888-98 . https://doi.org/10.1124/jpet.107.127639
Bongers, G M, Krueger, K M, Miller, T R, Baranowski, J L, Estvander, B R, Witte, D G, Strakhova, M I, van der Meer, P, Bakker, R A, Cowart, M D, Hancock, A A, Esbenshade, T A & Leurs, R 2007, ' An 80-amino acid deletion in the third intracellular loop of a naturally occurring human histamine H3 isoform confers pharmacological differences and constitutive activity ', The Journal of Pharmacology and Experimental Therapeutics, vol. 323, no. 3, pp. 888-98 . https://doi.org/10.1124/jpet.107.127639
In this article, we pharmacologically characterized two naturally occurring human histamine H3 receptor (hH3R) isoforms, hH3R(445) and hH3R(365). These abundantly expressed splice variants differ by a deletion of 80 amino acids in the intracellular l
Autor:
Ivan Milicic, Jorge D. Brioni, Deliang Zhou, Gerard B. Fox, Gerard D. Gagne, Ramin Faghih, Angela L. Molesky, Arthur A. Hancock, Kennan C. Marsh, Liping Pan, David G. Witte, Timothy A. Esbenshade, Jill M. Wetter, Kaitlin E. Browman, Michael J. Buckley, Gilbert Diaz, Xiaoqing Deng, Victoria A. Komater, John L. Baranowski, Thomas R. Miller, Marlon D. Cowart, Gregory A. Gfesser, Marilyn S. Diehl, Kathleen M. Krueger, Ellen M. Roberts
Publikováno v:
Biochemical Pharmacology. 73:1243-1255
Three novel heterocyclic benzofurans A-688057 ( 1 ), A-687136 ( 2 ), and A-698418 ( 3 ) were profiled for their in vitro and in vivo properties as a new series of histamine H 3 receptor antagonists. The compounds were all found to have nanomolar pote
Autor:
Arthur A. Hancock, Bruce W. Surber, Rahul Sharma, David G. Witte, Timothy A. Esbenshade, Tracy L. Carr, Betty B. Yao, Kathleen M. Krueger, Ramin Faghih, Thomas R. Miller, Steven Cassar
Publikováno v:
British Journal of Pharmacology. 148:657-670
A-349821 is a selective histamine H3 receptor antagonist/inverse agonist. Herein, binding of the novel non-imidazole H3 receptor radioligand [3H]A-349821 to membranes expressing native or recombinant H3 receptors from rat or human sources was charact
Autor:
S A Buckner, Lynne Ireland-Denny, Thomas R. Miller, Ivan Milicic, Kathleen M. Krueger, Timothy A. Esbenshade, John L. Baranowski, Arthur A. Hancock, David G. Witte
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 314:271-281
Previously reported pharmacological studies using the imidazole-containing histamine H3 receptor ligands GT-2331 (Cipralisant) and proxyfan resulted in a range of classifications (antagonist, agonist, and protean) for these compounds. We examined the
Autor:
Betty B. Yao, Ramin Faghih, Thomas R. Miller, Henry Zhang, Youssef L. Bennani, Timothy A. Esbenshade, David G. Witte, Gregory A. Gfesser, Gerard B. Fox, Jia Bao Pan, Arthur A. Hancock, Chae-Hee Kang, Jürgen Dinges, Kathy M. Krueger
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 14:673-676
Further SAR studies on novel histamine H(3) receptor antagonists are presented. Compound 14bb is a potent antagonist of both the rat cortical and human clone receptors, and is demonstrated to act functionally as an antagonist in an in vivo mouse dips
Publikováno v:
Journal of Neurochemistry. 63:980-987
Recent evidence suggests that the level of interleukin-6 (IL-6) is elevated in Alzheimer's disease (AD) brains. IL-6 is produced by reactive glial cells and could potentially affect neuronal survival. Understanding the biochemical mechanism that regu
Cerebrospinal fluid cytokine dynamics differ between Alzheimer disease patients and elderly controls
Autor:
Robert A. Lenz, Teresa Ellis, Viswanath Devanarayan, David G. Witte, Jeffrey F. Waring, Daniel A. Llano, Jinhe Li
Publikováno v:
Alzheimer disease and associated disorders. 26(4)
The time courses of levels of multiple plasma and cerebrospinal fluid (CSF) cytokines in patients with Alzheimer disease (AD) and in age-matched control subjects were compared. Interleukin (IL)-1β, IL-2, IL-6, IL-8, IL-10, IL-12p70, granulocyte-macr